Regeneron says its COVID-19 drug cut patient visits
Embed this video
Share
Description
Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced medical visits in a trial of nearly 800 patients. Gloria Tso reports.
General Info
UploadedOct 29, 2020
watch more videos